MS vs RYTM · P/E 20, $344.27B cap vs rev $130.1M
Morgan Stanley (MS) versus Rhythm Pharmaceuticals Inc (RYTM) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Rhythm Pharmaceuticals Inc (RYTM) is a biotechnology company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported RYTM revenue for 2024-12-31 was $130.1M. Net income was -$260.6M. Revenue was up 68.1% from 2023-12-31 to 2024-12-31. RYTM currently screens at market cap $6.49B.
MS currently screens at market cap $344.27B and trailing P/E 19.8. RYTM currently screens at market cap $6.49B.
Not investment advice. Open the MS and RYTM stock pages for the full models.
Not investment advice.